Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders
Author:
Chi Primus CheORCID, Owino Esther Awuor, Jao Irene, Olewe Fredrick, Ogutu Bernhards, Bejon Philip, Kapulu Melissa, Kamuya Dorcas, Marsh Vicki, Abdi Abdirahman I., Abebe Yonas, Audi Agnes, Billingsley Peter, Bull Peter C., Hamaluba Mainga, de Laurent Zaydah, Hodgson Susanne H., Hoffman Stephen, James Eric, Kamuyu Gathoni, Kariuki Silvia, Kibinge Nelson, Kimathi Rinter, Kinyanjui Sam, Kivisi Cheryl, Koskei Nelly, Imwong Mallika, Lowe Brett, Makale Johnstone, Marsh Kevin, Mohammed Khadija Said, Mosobo Moses, Murphy Sean C., Murungi Linda, Musyoki Jennifer, Muthui Michelle, Mwacharo Jedidah, Mwanga Daniel, Mwongeli Joyce, Ndungu Francis, Njue Maureen, Njuguna Patricia, Nyangweso George, Kimani Domitila, Ngoi Joyce M., Musembi Janet, Ngoto Omar, Otieno Edward, Osier Faith, Oloo James, Omuoyo Donwilliams, Ongecha John, Ongas Martin O., Ooko Michael, Shangala Jimmy, Sim Betty Kim Lee, Tarning Joel, Tuju James, Wambua Juliana, Williams Thomas N., Winterberg Markus,
Abstract
Abstract
Background
Human infection studies (HIS) that involve deliberately infecting healthy volunteers with a pathogen raise important ethical issues, including the need to ensure that benefits and burdens are understood and appropriately accounted for. Building on earlier work, we embedded social science research within an ongoing malaria human infection study in coastal Kenya to understand the study benefits and burdens experienced by study stakeholders in this low-resource setting and assess the wider implications for future research planning and policy.
Methods
Data were collected using qualitative research methods, including in-depth interviews (44), focus group discussions (10) and non-participation observation. Study participants were purposively selected (key informant or maximal diversity sampling), including volunteers in the human infection study, study staff, community representatives and local administrative authorities. Data were collected during and up to 18 months following study residency, from sites in Coastal and Western Kenya. Voice recordings of interviews and discussions were transcribed, translated, and analysed using framework analysis, combining data- and theory-driven perspectives.
Findings
Physical, psychological, economic and social forms of benefits and burdens were experienced across study stages. Important benefits for volunteers included the study compensation, access to health checks, good residential living conditions, new learning opportunities, developing friendships and satisfaction at contributing towards a new malaria vaccine. Burdens primarily affected study volunteers, including experiences of discomfort and ill health; fear and anxiety around aspects of the trial process, particularly deliberate infection and the implications of prolonged residency; anxieties about early residency exit; and interpersonal conflict. These issues had important implications for volunteers’ families, study staff and the research institution’s reputation more widely.
Conclusion
Developing ethically and scientifically strong HIS relies on grounded accounts of volunteers, study staff and the wider community, understood in the socioeconomic, political and cultural context where studies are implemented. Recognition of the diverse, and sometimes perverse, nature of potential benefits and burdens in a given context, and who this might implicate, is critical to this process. Prior and ongoing stakeholder engagement is core to developing these insights.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference43 articles.
1. Bambery B, Selgelid M, Weijer C, Savulescu J, Pollard AJ. Ethical criteria for human challenge studies in infectious diseases. Public Health Ethics. 2015;9(1):92–103. https://doi.org/10.1093/phe/phv026. 2. Franklin GM, Grady C. The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis. 2001;33(7):1028–33. 3. Hodgson SH, et al. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection. Front Microbiol. 2014;5:686. 4. Shah SK, Kimmelman J, Lyerly AD, Lynch HF, McCutchan F, Miller F, et al. Ethical Considerations for Zika Virus Human Challenge Trials: Report & Recommendations. National Institute of Allergy and Infectious Diseases. February 2017. https://www.niaid.nih.gov/sites/default/files/EthicsZikaHumanChallengeStudiesReport2017.pdf. Accessed 17 Nov 2020. 5. Kapulu MC, Njuguna P, Hamaluba MM, CHMI-SIKA Study Team. Controlled human malaria infection in semi-ommune Kenyan adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity. Wellcome Open Res. 2019;3:155. https://doi.org/10.12688/wellcomeopenres.14909.2.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|